Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship, Cardiology, Duke University School of Medicine 2015 - 2020
  • Residency, Internal Medicine, Northwestern University 2012 - 2015
  • M.D., Northwestern University, Feinberg School of Medicine 2012
• 

  Duke Appointment History

  • Assistant Professor of Medicine, Medicine, Cardiology, Medicine 2020
• Research
• 

  Selected Grants

  • Comparison of Dyspnea Measurement Instruments in Acute Heart Failure awarded by Heart Failure Society of America 2017 - 2019
• 

  External Relationships

  • Amgen, Inc.
  • AstraZeneca
  • Bristol-Myers Squibb
  • Cytokinetics, Inc.
  • Merck Sharpe & Dohme (Merck & Co, USA)
  • Novartis
  • Pfizer Inc.
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Salah, Husam M., Marat Fudim, Subhi J. Al’Aref, Muhammad Shahzeb Khan, Zaid I. Almarzooq, Subodh R. Devabhaktuni, Robert J. Mentz, Javed Butler, and Stephen J. Greene. “Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction.” Am J Cardiol 145 (April 15, 2021): 165–68. https://doi.org/10.1016/j.amjcard.2021.01.013.
       Full Text  Link to Item
    • Chow, Christine, Robert J. Mentz, and Stephen J. Greene. “Update on the Impact of Comorbidities on the Efficacy and Safety of Heart Failure Medications.” Curr Heart Fail Rep, April 9, 2021. https://doi.org/10.1007/s11897-021-00512-3.
       Full Text  Link to Item
    • Greene, Stephen J., Javed Butler, and Gregg C. Fonarow. “Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure-Optimizing Therapy With the Need for Speed.” Jama Cardiol, March 31, 2021. https://doi.org/10.1001/jamacardio.2021.0496.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Gregg C. Fonarow, and Stephen J. Greene. “Sodium-glucose co-transporter 2 inhibitors for heart failure: clinical trial efficacy and clinical practice effectiveness.” Eur J Heart Fail, March 29, 2021. https://doi.org/10.1002/ejhf.2170.
       Full Text  Link to Item
    • Greene, Stephen J., Javed Butler, John A. Spertus, Anne S. Hellkamp, Muthiah Vaduganathan, Adam D. DeVore, Nancy M. Albert, et al. “Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.” Jama Cardiol, March 24, 2021. https://doi.org/10.1001/jamacardio.2021.0372.
       Full Text  Link to Item
    • Greene, Stephen J., and Muhammad Shahzeb Khan. “Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care.” J Am Coll Cardiol 77, no. 11 (March 23, 2021): 1408–11. https://doi.org/10.1016/j.jacc.2021.02.006.
       Full Text  Link to Item
    • Brooksbank, Jeremy A., Stephen J. Greene, Hailey M. Harris, Amanda Stebbins, Mona Fiuzat, David J. Whellan, Brooke Alhanti, et al. “Beta-blocker and ACE-inhibitor dosing as a function of body surface area: From the HF-ACTION trial.” Am Heart J 233 (March 2021): 1–4. https://doi.org/10.1016/j.ahj.2020.11.003.
       Full Text  Link to Item
    • Salah, Husam M., Subhi J. Al’Aref, Muhammad Shahzeb Khan, Malek Al-Hawwas, Srikanth Vallurupalli, Jawahar L. Mehta, J Paul Mounsey, et al. “Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update.” Am Heart J 233 (March 2021): 86–91. https://doi.org/10.1016/j.ahj.2020.12.007.
       Full Text  Link to Item
    • Greene, Stephen J., Taylor S. Triana, Raluca Ionescu-Ittu, Sherry Shi, Annie Guérin, Mary M. DeSouza, Paul D. Kessler, Aylin Tugcu, Maria Borentain, and G Michael Felker. “Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.” J Am Coll Cardiol 77, no. 7 (February 23, 2021): 1023–25. https://doi.org/10.1016/j.jacc.2020.12.026.
       Full Text  Link to Item
    • Felker, G Michael, and Stephen J. Greene. “Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.” J Am Coll Cardiol 77, no. 6 (February 16, 2021): 709–12. https://doi.org/10.1016/j.jacc.2020.12.018.
       Full Text  Link to Item
    • Blumer, Vanessa, Miguel Ortiz Bezara, Veraprapas Kittipibul, Stephen J. Greene, Marat Fudim, Gabriel A. Hernandez, Sandra Chaparro, and Emer Joyce. “Impact of Atrial Fibrillation on In-Hospital Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation.” J Cardiovasc Transl Res 14, no. 1 (February 2021): 120–24. https://doi.org/10.1007/s12265-020-09968-5.
       Full Text  Link to Item
    • Brooksbank, Jeremy A., Stephen J. Greene, Tracy A. DeWald, and Robert J. Mentz. “Body surface area and medication dosing in patients with heart failure with reduced ejection fraction.” Trends Cardiovasc Med 31, no. 2 (February 2021): 111–16. https://doi.org/10.1016/j.tcm.2019.12.011.
       Full Text  Link to Item
    • Fudim, Marat, Nicolas Ashur, Aaron D. Jones, Andrew P. Ambrosy, Bradley A. Bart, Javed Butler, Horng H. Chen, et al. “Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis.” Esc Heart Fail 8, no. 1 (February 2021): 662–69. https://doi.org/10.1002/ehf2.13159.
       Full Text  Link to Item
    • Hamo, Carine E., Gregg C. Fonarow, Stephen J. Greene, Muthiah Vaduganathan, Clyde W. Yancy, Paul Heidenreich, Di Lu, Roland A. Matsouaka, Adam D. DeVore, and Javed Butler. “Temporal trends in risk profiles among patients hospitalized for heart failure.” Am Heart J 232 (February 2021): 154–63. https://doi.org/10.1016/j.ahj.2020.11.015.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Izza Shahid, Nava Asad, Stephen J. Greene, Safi U. Khan, Rami Doukky, Marco Metra, et al. “Discontinuation and non-publication of heart failure randomized controlled trials: a call to publish all trial results.” Esc Heart Fail 8, no. 1 (February 2021): 16–25. https://doi.org/10.1002/ehf2.13099.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Muhammad Arbaz Arshad Khan, Simra Irfan, Tariq Jamal Siddiqi, Stephen J. Greene, Stefan D. Anker, Jayakumar Sreenivasan, et al. “Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials.” Esc Heart Fail 8, no. 1 (February 2021): 26–36. https://doi.org/10.1002/ehf2.13122.
       Full Text  Link to Item
    • Salah, Husam M., Subhi J. Al’Aref, Muhammad Shahzeb Khan, Malek Al-Hawwas, Srikanth Vallurupalli, Jawahar L. Mehta, J Paul Mounsey, et al. “Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.” Am Heart J 232 (February 2021): 10–22. https://doi.org/10.1016/j.ahj.2020.10.064.
       Full Text  Link to Item
    • Greene, Stephen J., Xi Tan, Yu-Chen Yeh, Mark Bernauer, Omer Zaidi, Mei Yang, and Javed Butler. “Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction.” Heart Fail Rev, January 20, 2021. https://doi.org/10.1007/s10741-021-10077-x.
       Full Text  Link to Item
    • Bhatt, Ankeet S., William T. Abraham, JoAnn Lindenfeld, Michael Bristow, Peter E. Carson, G Michael Felker, Gregg C. Fonarow, et al. “Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory.” Jacc Heart Fail 9, no. 1 (January 2021): 1–12. https://doi.org/10.1016/j.jchf.2020.10.014.
       Full Text  Link to Item
    • Greene, Stephen J., Srinath Adusumalli, Nancy M. Albert, Paul J. Hauptman, Michael W. Rich, Paul A. Heidenreich, Javed Butler, and Javed Heart Failure Society of America Quality of Care Committee. “Building a Heart Failure Clinic: A Practical Guide from the Heart Failure Society of America.” J Card Fail 27, no. 1 (January 2021): 2–19. https://doi.org/10.1016/j.cardfail.2020.10.008.
       Full Text  Link to Item
    • Fudim, Marat, Jeremy Brooksbank, Anna Giczewska, Stephen J. Greene, Justin L. Grodin, Pieter Martens, Jozine M. Ter Maaten, et al. “Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HF.” J Am Heart Assoc 9, no. 24 (December 15, 2020): e015752. https://doi.org/10.1161/JAHA.119.015752.
       Full Text  Open Access Copy  Link to Item
    • Blumer, Vanessa, Stephen J. Greene, Miguel Ortiz, Veraprapas Kittipibul, Gabriel A. Hernandez, Marat Fudim, Alejandro Lemor, Robert J. Mentz, and Amanda R. Vest. “In-hospital outcomes after bariatric surgery in patients with heart failure.” Am Heart J 230 (December 2020): 59–62. https://doi.org/10.1016/j.ahj.2020.09.007.
       Full Text  Link to Item
    • Butler, Javed, Muhammad Shariq Usman, Muhammad Shahzeb Khan, Stephen J. Greene, Tim Friede, Muthiah Vaduganathan, Gerasimos Filippatos, Andrew J Stewart Coats, and Stefan D. Anker. “Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis.” Esc Heart Fail 7, no. 6 (December 2020): 3298–3309. https://doi.org/10.1002/ehf2.13169.
       Full Text  Link to Item
    • Grubb, Alex F., Christopher A. Pumill, Stephen J. Greene, Angie Wu, Karen Chiswell, and Robert J. Mentz. “Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center.” Am Heart J 230 (December 2020): 25–34. https://doi.org/10.1016/j.ahj.2020.09.011.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Javed Butler, and Stephen J. Greene. “The Time Is Now for Sodium Glucose Co-Transporter 2 Inhibitors for Heart Failure: A Call to Overcome Clinical Inertia.” Circ Heart Fail 13, no. 12 (December 2020): e008030. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008030.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Shuaiqi Zhang, Maria Grau-Sepulveda, Adam D. DeVore, Javed Butler, Paul A. Heidenreich, et al. “Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry.” Jama Cardiol, November 13, 2020. https://doi.org/10.1001/jamacardio.2020.5864.
       Full Text  Link to Item
    • Greene, Stephen J., Taylor S. Triana, Raluca Ionescu-Ittu, Rebecca M. Burne, Annie Guérin, Maria Borentain, Paul D. Kessler, et al. “In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States.” Jacc Heart Fail 8, no. 11 (November 2020): 943–53. https://doi.org/10.1016/j.jchf.2020.05.013.
       Full Text  Link to Item
    • Greene, Stephen J., Robert J. Mentz, Alexander T. Limkakeng, Thomas Irons, Tracy Truong, Cynthia L. Green, Carrie Nowak, Vanessa Blumer, and Peter S. Pang. “Comparison of Dyspnea Measurement Instruments in Acute Heart Failure: The DYSPNEA-AHF Pilot Study.” J Card Fail, October 20, 2020. https://doi.org/10.1016/j.cardfail.2020.10.004.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Javed Butler, and Stephen J. Greene. “The real world of de novo heart failure: the next frontier for heart failure clinical trials?” Eur J Heart Fail 22, no. 10 (October 2020): 1786–89. https://doi.org/10.1002/ejhf.1844.
       Full Text  Link to Item
    • Mann, Douglas L., Stephen J. Greene, Michael M. Givertz, Justin M. Vader, Randall C. Starling, Andrew P. Ambrosy, Palak Shah, et al. “Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial.” Jacc Heart Fail 8, no. 10 (October 2020): 789–99. https://doi.org/10.1016/j.jchf.2020.05.005.
       Full Text  Link to Item
    • Selvaraj, Senthil, Stephen J. Greene, Sameed Ahmed M. Khatana, Ashwin S. Nathan, Scott D. Solomon, and Deepak L. Bhatt. “The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19.” J Am Heart Assoc 9, no. 18 (September 15, 2020): e018274. https://doi.org/10.1161/JAHA.120.018274.
       Full Text  Link to Item
    • Greene, Stephen J., and Adam D. DeVore. “The Maximally Tolerated Dose: The Key Context for Interpreting Subtarget Medication Dosing for Heart Failure.” Jacc Heart Fail 8, no. 9 (September 2020): 739–41. https://doi.org/10.1016/j.jchf.2020.05.011.
       Full Text  Link to Item
    • Usman, Muhammad Shariq, Tariq Jamal Siddiqi, Muhammad Shahzeb Khan, Areeba Ahmed, Syed Saad Ali, Erin D. Michos, Michael E. Hall, et al. “A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.” Am J Cardiol 130 (September 1, 2020): 159–61. https://doi.org/10.1016/j.amjcard.2020.05.038.
       Full Text  Link to Item
    • Reza, Nosheen, Ayman Samman Tahhan, Nadim Mahmud, Ersilia M. DeFilippis, Alaaeddin Alrohaibani, Muthiah Vaduganathan, Stephen J. Greene, et al. “Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials.” Circ Heart Fail 13, no. 8 (August 2020): e006605. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006605.
       Full Text  Link to Item
    • Khan, Safi, Muhammad Z. Khan, Muhammad Shahzeb Khan, Stephen Greene, Muhammad Usman Khan, Richard A. Krasuski, Haider J. Warraich, and Erin D. Michos. “Deaths in pulmonary hypertension: US location trends.” Bmj Support Palliat Care, July 24, 2020. https://doi.org/10.1136/bmjspcare-2020-002254.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Javed Butler, and Stephen J. Greene. “Recognizing the Significance of Outpatient Worsening Heart Failure.” J Am Heart Assoc 9, no. 14 (July 21, 2020): e017485. https://doi.org/10.1161/JAHA.120.017485.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Izza Shahid, Tariq Jamal Siddiqi, Safi U. Khan, Haider J. Warraich, Stephen J. Greene, Javed Butler, and Erin D. Michos. “Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.” J Am Heart Assoc 9, no. 11 (June 2, 2020): e015594. https://doi.org/10.1161/JAHA.119.015594.
       Full Text  Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, and Javed Butler. “Risk Profiles in Heart Failure: Baseline, Residual, Worsening, and Advanced Heart Failure Risk.” Circ Heart Fail 13, no. 6 (June 2020): e007132. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007132.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Ayman Samman Tahhan, Muthiah Vaduganathan, Stephen J. Greene, Alaaeddin Alrohaibani, Stefan D. Anker, Orly Vardeny, Gregg C. Fonarow, and Javed Butler. “Trends in prevalence of comorbidities in heart failure clinical trials.” Eur J Heart Fail 22, no. 6 (June 2020): 1032–42. https://doi.org/10.1002/ejhf.1818.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Javed Butler, and Stephen J. Greene. “Patient-reported outcomes for heart failure with preserved ejection fraction: conducting quality studies on quality of life.” Eur J Heart Fail 22, no. 6 (June 2020): 1019–21. https://doi.org/10.1002/ejhf.1762.
       Full Text  Link to Item
    • Tahhan, Ayman Samman, Muthiah Vaduganathan, Stephen J. Greene, Alaaeddin Alrohaibani, Mohamed Raad, Mazen Gafeer, Roxana Mehran, et al. “Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.” Jama Cardiol 5, no. 6 (June 1, 2020): 714–22. https://doi.org/10.1001/jamacardio.2020.0359.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Gregg C. Fonarow, Stephen J. Greene, Adam D. DeVore, Abhishek Kavati, Slaven Sikirica, Nancy M. Albert, et al. “Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.” Jacc Heart Fail 8, no. 6 (June 2020): 469–80. https://doi.org/10.1016/j.jchf.2019.12.015.
       Full Text  Link to Item
    • Butler, Javed, Stephen J. Greene, Svati H. Shah, Sanjiv J. Shah, Kevin J. Anstrom, Raymond J. Kim, Andreas P. Kalogeropoulos, et al. “Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study.” J Card Fail 26, no. 5 (May 2020): 371–80. https://doi.org/10.1016/j.cardfail.2019.10.011.
       Full Text  Link to Item
    • Redouane, Brahim, Stephen J. Greene, Marat Fudim, Muthiah Vaduganathan, Andrew P. Ambrosy, Jie-Lena Sun, Adam D. DeVore, et al. “Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial.” Circ Heart Fail 13, no. 5 (May 2020): e006758. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006758.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Muhammad Mustafa Memon, Mohammad H. Murad, Muthiah Vaduganathan, Stephen J. Greene, Michael Hall, Filippos Triposkiadis, et al. “Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis.” Eur J Heart Fail 22, no. 3 (March 2020): 472–85. https://doi.org/10.1002/ejhf.1643.
       Full Text  Link to Item
    • Myhre, Peder L., Muthiah Vaduganathan, and Stephen J. Greene. “Diagnosing heart failure with preserved ejection fraction in 2019: the search for a gold standard.” Eur J Heart Fail 22, no. 3 (March 2020): 422–24. https://doi.org/10.1002/ejhf.1638.
       Full Text  Link to Item
    • Samsky, Marc D., Li Lin, Stephen J. Greene, Steven J. Lippmann, Pamela N. Peterson, Paul A. Heidenreich, Warren K. Laskey, et al. “Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.” Jama Cardiol 5, no. 3 (March 1, 2020): 292–99. https://doi.org/10.1001/jamacardio.2019.4987.
       Full Text  Link to Item
    • Fudim, Marat, Jacob P. Kelly, Aaron D. Jones, Omar F. AbouEzzeddine, Andrew P. Ambrosy, Stephen J. Greene, Yogesh N. V. Reddy, et al. “Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?” Am Heart J 220 (February 2020): 97–107. https://doi.org/10.1016/j.ahj.2019.11.006.
       Full Text  Link to Item
    • Bhatt, Ankeet S., Muthiah Vaduganathan, Ravi B. Patel, Gregg C. Fonarow, Haris P. Subacius, Marvin A. Konstam, Faiez Zannad, Javed Butler, and Stephen J. Greene. “Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.” Eur J Heart Fail 22, no. 1 (January 2020): 164–67. https://doi.org/10.1002/ejhf.1651.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Gregg C. Fonarow, Stephen J. Greene, Adam D. DeVore, Nancy M. Albert, Carol I. Duffy, C Larry Hill, John A. Spertus, Laine E. Thomas, and Javed Butler. “Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus.” J Am Coll Cardiol 74, no. 25 (December 24, 2019): 3176–78. https://doi.org/10.1016/j.jacc.2019.10.020.
       Full Text  Link to Item
    • Butler, Javed, Milton Packer, Stephen J. Greene, Mona Fiuzat, Stefan D. Anker, Kevin J. Anstrom, Peter E. Carson, et al. “Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.” Circulation 140, no. 25 (December 17, 2019): 2108–18. https://doi.org/10.1161/CIRCULATIONAHA.119.042155.
       Full Text  Link to Item
    • Blumer, Vanessa, Stephen J. Greene, Jie-Lena Sun, Bradley A. Bart, Andrew P. Ambrosy, Javed Butler, Adam D. DeVore, et al. “Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS-HF trial.” Eur J Heart Fail 21, no. 11 (November 2019): 1472–76. https://doi.org/10.1002/ejhf.1592.
       Full Text  Link to Item
    • Greene, Stephen J., Adam D. DeVore, Shubin Sheng, Gregg C. Fonarow, Javed Butler, Robert M. Califf, Adrian F. Hernandez, et al. “Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.” Jacc Heart Fail 7, no. 11 (November 2019): 980–92. https://doi.org/10.1016/j.jchf.2019.07.011.
       Full Text  Link to Item
    • O’Brien, Emily C., and Stephen J. Greene. “Real-World Evidence for Medication Safety: Causal, Confounded, or Capable?” Jacc Heart Fail 7, no. 10 (October 2019): 846–48. https://doi.org/10.1016/j.jchf.2019.05.003.
       Full Text  Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, and Javed Butler. “Reply: Titration of Guideline-Directed Medical Therapy Improves Patient-Centered Outcomes in Heart Failure With Reduced Ejection Fraction.” J Am Coll Cardiol 74, no. 10 (September 10, 2019): 1426–27. https://doi.org/10.1016/j.jacc.2019.06.061.
       Full Text  Link to Item
    • Friedman, Daniel J., Stephen J. Greene, Jonathan P. Piccini, Sreekanth Vemulapalli, and Kevin P. Jackson. “Watchman implantation in a patient with left atrial appendage thrombus.” J Cardiovasc Electrophysiol 30, no. 9 (September 2019): 1694–95. https://doi.org/10.1111/jce.14031.
       Full Text  Link to Item
    • Greene, Stephen J., G Michael Felker, Anna Giczewska, Andreas P. Kalogeropoulos, Andrew P. Ambrosy, Hrishikesh Chakraborty, Adam D. DeVore, et al. “Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial.” Can J Cardiol 35, no. 9 (September 2019): 1097–1105. https://doi.org/10.1016/j.cjca.2019.01.022.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Robert J. Mentz, Mona Fiuzat, John G. F. Cleland, Stephen J. Greene, Christopher M. O’Connor, John R. Teerlink, Faiez Zannad, and Scott D. Solomon. “Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972].” Eur J Heart Fail 21, no. 6 (June 2019): 819. https://doi.org/10.1002/ejhf.1480.
       Full Text  Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, Adam D. DeVore, Puza P. Sharma, Muthiah Vaduganathan, Nancy M. Albert, Carol I. Duffy, et al. “Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.” J Am Coll Cardiol 73, no. 19 (May 21, 2019): 2365–83. https://doi.org/10.1016/j.jacc.2019.02.015.
       Full Text  Link to Item
    • Psotka, Mitchell A., Susan E. Ammon, Mona Fiuzat, Biykem Bozkurt, Eugene S. Chung, Robert T. Cole, Stephen J. Greene, et al. “Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey.” Jacc Heart Fail 7, no. 5 (May 2019): 431–38. https://doi.org/10.1016/j.jchf.2019.02.008.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Gregory D. Lewis, Rajeev Malhotra, Aaron D. Jones, Stephen J. Greene, Marat Fudim, Adrian Coles, et al. “Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial.” J Cardiovasc Med (Hagerstown) 20, no. 4 (April 2019): 223–25. https://doi.org/10.2459/JCM.0000000000000736.
       Full Text  Link to Item
    • Greene, Stephen J., and Robert M. Califf. “Reframing Global Variation in Heart Failure Trials: Thinking Beyond Location on the Map.” Jacc Heart Fail 7, no. 4 (April 2019): 347–49. https://doi.org/10.1016/j.jchf.2018.12.012.
       Full Text  Link to Item
    • Greene, Stephen J., Lauren E. Wilson, Siddique A. Abbasi, Akeem A. Yusuf, and Bradley G. Hammill. “Outpatient Intravenous Diuretic Therapy for Heart Failure in the United States.” J Am Coll Cardiol 73, no. 9 (March 12, 2019): 1101–3. https://doi.org/10.1016/j.jacc.2018.12.034.
       Full Text  Link to Item
    • Marti, Catherine N., Gregg C. Fonarow, Stefan D. Anker, Clyde Yancy, Muthiah Vaduganathan, Stephen J. Greene, Ali Ahmed, et al. “Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges.” Eur J Heart Fail 21, no. 3 (March 2019): 286–96. https://doi.org/10.1002/ejhf.1351.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Ayman Samman Tahhan, Alaaeddin Alrohaibani, Stephen J. Greene, Gregg C. Fonarow, Orly Vardeny, JoAnn Lindenfeld, et al. “Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?” Jacc Heart Fail 7, no. 3 (March 2019): 267–71. https://doi.org/10.1016/j.jchf.2018.12.016.
       Full Text  Link to Item
    • Greene, Stephen J., and Javed Butler. “Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.” Circulation 139, no. 2 (January 8, 2019): 152–54. https://doi.org/10.1161/CIRCULATIONAHA.118.037599.
       Full Text  Link to Item
    • Bhagat, Aditi A., Stephen J. Greene, Muthiah Vaduganathan, Gregg C. Fonarow, and Javed Butler. “Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization.” Jacc Heart Fail 7, no. 1 (January 2019): 1–12. https://doi.org/10.1016/j.jchf.2018.06.011.
       Full Text  Link to Item
    • Eisenstein, Eric L., Kristi Prather, Stephen J. Greene, Tina Harding, Amanda Harrington, Davera Gabriel, Ingrid Jones, Robert J. Mentz, Eric J. Velazquez, and Kevin J. Anstrom. “Death: The Simple Clinical Trial Endpoint.” Stud Health Technol Inform 257 (2019): 86–91.
       Link to Item
    • Greene, Stephen J., G Michael Felker, and Javed Butler. “Outpatient versus inpatient worsening heart failure: distinguishing biology and risk from location of care.” Eur J Heart Fail 21, no. 1 (January 2019): 121–24. https://doi.org/10.1002/ejhf.1341.
       Full Text  Link to Item
    • Greene, Stephen J., and G Michael Felker. “The Urgency of Doing: Addressing Gaps in Use of Evidence-Based Medical Therapy for Heart Failure.” Jacc Heart Fail 7, no. 1 (January 2019): 22–24. https://doi.org/10.1016/j.jchf.2018.11.006.
       Full Text  Link to Item
    • Patel, Ravi B., Muthiah Vaduganathan, Aruna Rikhi, Hrishikesh Chakraborty, Stephen J. Greene, Adrian F. Hernandez, G Michael Felker, Margaret M. Redfield, Javed Butler, and Sanjiv J. Shah. “History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.” Jacc Heart Fail 7, no. 1 (January 2019): 47–55. https://doi.org/10.1016/j.jchf.2018.09.008.
       Full Text  Link to Item
    • Kochar, Ajar, Jennifer Rymer, Zainab Samad, and Zainab Duke Cardiovascular Education Group. “Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education?” J Am Coll Cardiol 72, no. 25 (December 25, 2018): 3366–69. https://doi.org/10.1016/j.jacc.2018.11.007.
       Full Text  Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, Scott D. Solomon, Haris P. Subacius, Muthiah Vaduganathan, Andrew P. Ambrosy, Marat Fudim, et al. “Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial.” Eur J Heart Fail 20, no. 12 (December 2018): 1760–63. https://doi.org/10.1002/ejhf.1310.
       Full Text  Link to Item
    • Hernandez, Adrian F., Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel P. Jones, Lawrence A. Leiter, et al. “Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.” Lancet 392, no. 10157 (October 27, 2018): 1519–29. https://doi.org/10.1016/S0140-6736(18)32261-X.
       Full Text  Link to Item
    • Alkhawam, Lora, and Stephen J. Greene. “Bulletproof heart: Gunshot wound to the ventricular septum without pericardial effusion or hemodynamic collapse.” Cjem 20, no. S2 (October 2018): S40. https://doi.org/10.1017/cem.2017.340.
       Full Text  Link to Item
    • Fudim, Marat, Rahul Loungani, Shannon M. Doerfler, Adrian Coles, Stephen J. Greene, Lauren B. Cooper, Mona Fiuzat, Christopher M. O’Connor, Joseph G. Rogers, and Robert J. Mentz. “Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial.” Am Heart J 204 (October 2018): 163–73. https://doi.org/10.1016/j.ahj.2018.07.019.
       Full Text  Link to Item
    • Greene, Stephen J., Adrian F. Hernandez, Jie-Lena Sun, Javed Butler, Paul W. Armstrong, Justin A. Ezekowitz, Faiez Zannad, et al. “Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.” Circulation. Cardiovascular Quality and Outcomes 11, no. 10 (October 2018): e004783. https://doi.org/10.1161/circoutcomes.118.004783.
       Full Text
    • Patel, Ravi B., Muthiah Vaduganathan, Stephen J. Greene, and Javed Butler. “Nomenclature in heart failure: a call for objective, reproducible, and biologically-driven terminology.” Eur J Heart Fail 20, no. 10 (October 2018): 1379–81. https://doi.org/10.1002/ejhf.1231.
       Full Text  Link to Item
    • Tahhan, Ayman Samman, Muthiah Vaduganathan, Stephen J. Greene, Gregg C. Fonarow, Mona Fiuzat, Mariell Jessup, JoAnn Lindenfeld, Christopher M. O’Connor, and Javed Butler. “Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review.” Jama Cardiol 3, no. 10 (October 1, 2018): 1011–19. https://doi.org/10.1001/jamacardio.2018.2559.
       Full Text  Link to Item
    • Greene, Stephen J., Robert J. Mentz, Mona Fiuzat, Javed Butler, Scott D. Solomon, Andrew P. Ambrosy, Cyrus Mehta, John R. Teerlink, Faiez Zannad, and Christopher M. O’Connor. “Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure.” Circulation 138, no. 10 (September 4, 2018): 1039–53. https://doi.org/10.1161/CIRCULATIONAHA.118.034668.
       Full Text  Link to Item
    • Iorio, Annamaria, Michele Senni, Giulia Barbati, Stephen J. Greene, Stefano Poli, Elena Zambon, Concetta Di Nora, et al. “Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.” Eur J Heart Fail 20, no. 9 (September 2018): 1257–66. https://doi.org/10.1002/ejhf.1202.
       Full Text  Link to Item
    • Samman Tahhan, Ayman, Muthiah Vaduganathan, Sonali Kumar, Maureen Okafor, Stephen J. Greene, and Javed Butler. “Design Elements and Enrollment Patterns of Contemporary Trials in Heart Failure With Preserved Ejection Fraction: A Systematic Review.” Jacc Heart Fail 6, no. 8 (August 2018): 714–17. https://doi.org/10.1016/j.jchf.2018.04.014.
       Full Text  Link to Item
    • Greene, Stephen J., Javed Butler, Nancy M. Albert, Adam D. DeVore, Puza P. Sharma, Carol I. Duffy, C Larry Hill, et al. “Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.” J Am Coll Cardiol 72, no. 4 (July 24, 2018): 351–66. https://doi.org/10.1016/j.jacc.2018.04.070.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Ravi B. Patel, Robert J. Mentz, Haris Subacius, Neal A. Chatterjee, Stephen J. Greene, Andrew P. Ambrosy, et al. “Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial).” Am J Cardiol 122, no. 2 (July 15, 2018): 255–60. https://doi.org/10.1016/j.amjcard.2018.03.362.
       Full Text  Link to Item
    • Mentz, Robert J., and Stephen J. Greene. “Adding Troponin to the Puzzle of Heart Failure With Preserved Ejection Fraction: Marker or Mediator?” J Am Coll Cardiol 72, no. 1 (July 3, 2018): 41–44. https://doi.org/10.1016/j.jacc.2018.04.038.
       Full Text  Link to Item
    • Njoroge, Joyce N., Baljash Cheema, Andrew P. Ambrosy, Stephen J. Greene, Sean P. Collins, Muthiah Vaduganathan, Alexandre Mebazaa, Ovidiu Chioncel, Javed Butler, and Mihai Gheorghiade. “Expanded algorithm for managing patients with acute decompensated heart failure.” Heart Fail Rev 23, no. 4 (July 2018): 597–607. https://doi.org/10.1007/s10741-018-9697-9.
       Full Text  Link to Item
    • Greene, Stephen J., Emily C. O’Brien, Robert J. Mentz, Nancy Luo, N Chantelle Hardy, Warren K. Laskey, Paul A. Heidenreich, et al. “Home-Time After Discharge Among Patients Hospitalized With Heart Failure.” J Am Coll Cardiol 71, no. 23 (June 12, 2018): 2643–52. https://doi.org/10.1016/j.jacc.2018.03.517.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Robert J. Mentz, Mona Fiuzat, John G. F. Cleland, Stephen J. Greene, Christopher M. O’Connor, John R. Teerlink, Faiez Zannad, and Scott D. Solomon. “The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions.” Eur J Heart Fail 20, no. 6 (June 2018): 963–72. https://doi.org/10.1002/ejhf.1159.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Ayman Samman Tahhan, Stephen J. Greene, Maureen Okafor, Sonali Kumar, and Javed Butler. “Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years.” Eur J Heart Fail 20, no. 6 (June 2018): 1068–71. https://doi.org/10.1002/ejhf.1130.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Ankeet S. Bhatt, Amanda L. Stebbins, Lisa M. Wruck, Marat Fudim, Stephen J. Greene, William E. Kraus, et al. “Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.” Am Heart J 199 (May 2018): 97–104. https://doi.org/10.1016/j.ahj.2018.02.004.
       Full Text  Link to Item
    • Cerbin, Lukasz P., Andrew P. Ambrosy, Stephen J. Greene, Paul W. Armstrong, Javed Butler, Adrian Coles, Adam D. DeVore, et al. “Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.” Jacc Heart Fail 6, no. 4 (April 2018): 298–307. https://doi.org/10.1016/j.jchf.2018.01.018.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Baljash Cheema, Erin Cleveland, Kamya Sankar, Haris Subacius, Gregg C. Fonarow, Scott D. Solomon, et al. “Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.” Eur J Heart Fail 20, no. 4 (April 2018): 677–86. https://doi.org/10.1002/ejhf.973.
       Full Text  Link to Item
    • Greene, Stephen J., Muthiah Vaduganathan, Muhammad Shahzeb Khan, George L. Bakris, Matthew R. Weir, Jonathan H. Seltzer, Naveed Sattar, et al. “Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.” J Am Coll Cardiol 71, no. 12 (March 27, 2018): 1379–90. https://doi.org/10.1016/j.jacc.2018.01.047.
       Full Text  Link to Item
    • Greene, Stephen J., Robert J. Mentz, and G Michael Felker. “Outpatient Worsening Heart Failure as a Target for Therapy: A Review.” Jama Cardiol 3, no. 3 (March 1, 2018): 252–59. https://doi.org/10.1001/jamacardio.2017.5250.
       Full Text  Link to Item
    • Greene, Stephen J., and Robert J. Mentz. “Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?” Eur J Heart Fail 20, no. 3 (March 2018): 471–73. https://doi.org/10.1002/ejhf.1024.
       Full Text  Link to Item
    • Fudim, Marat, Christopher M. O’Connor, Allison Dunning, Andrew P. Ambrosy, Paul W. Armstrong, Adrian Coles, Justin A. Ezekowitz, et al. “Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.” Eur J Heart Fail 20, no. 2 (February 2018): 304–14. https://doi.org/10.1002/ejhf.1020.
       Full Text  Link to Item
    • Greene, Stephen J., Javed Butler, Gregg C. Fonarow, Haris P. Subacius, Andrew P. Ambrosy, Muthiah Vaduganathan, Marco Triggiani, et al. “Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial.” Eur J Heart Fail 20, no. 2 (February 2018): 281–91. https://doi.org/10.1002/ejhf.1019.
       Full Text  Link to Item
    • Greene, Stephen J., and G Michael Felker. “Considering the duration of heart failure: using the past to predict the future.” Eur J Heart Fail 20, no. 2 (February 2018): 382–84. https://doi.org/10.1002/ejhf.1064.
       Full Text  Link to Item
    • Greene, Stephen J., and G Michael Felker. “Innovation in Diuretic Therapy: The Missing Ingredient for Treating Worsening Heart Failure Outside the Hospital?” Jacc Basic Transl Sci 3, no. 1 (February 2018): 35–37. https://doi.org/10.1016/j.jacbts.2018.01.002.
       Full Text  Link to Item
    • Samman Tahhan, Ayman, Muthiah Vaduganathan, Stephen J. Greene, Maureen Okafor, Sonali Kumar, and Javed Butler. “Evolving Landscape of Clinical Trials in Heart Failure: Patient Populations, Endpoint Selection, and Regions of Enrollment.” Curr Heart Fail Rep 15, no. 1 (February 2018): 10–16. https://doi.org/10.1007/s11897-018-0374-z.
       Full Text  Link to Item
    • Gori, Mauro, Paolo Canova, Alice Calabrese, Giovanni Cioffi, Roberto Trevisan, Renata De Maria, Aurelia Grosu, et al. “Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study.” Int J Cardiol 248 (December 1, 2017): 414–20. https://doi.org/10.1016/j.ijcard.2017.06.101.
       Full Text  Link to Item
    • Chioncel, Ovidiu, Sean P. Collins, Stephen J. Greene, Peter S. Pang, Andrew P. Ambrosy, Elena-Laura Antohi, Muthiah Vaduganathan, Javed Butler, and Mihai Gheorghiade. “Predictors of Post-discharge Mortality Among Patients Hospitalized for Acute Heart Failure.” Card Fail Rev 3, no. 2 (November 2017): 122–29. https://doi.org/10.15420/cfr.2017:12:1.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Gregg C. Fonarow, Hassan Khan, Stephen J. Greene, Stefan D. Anker, Mihai Gheorghiade, and Javed Butler. “Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.” Esc Heart Fail 4, no. 4 (November 2017): 402–8. https://doi.org/10.1002/ehf2.12204.
       Full Text  Link to Item
    • Cheema, Baljash S., Hani N. Sabbah, Stephen J. Greene, and Mihai Gheorghiade. “Protein turnover in the failing heart: an ever-changing landscape.” Eur J Heart Fail 19, no. 10 (October 2017): 1218–21. https://doi.org/10.1002/ejhf.905.
       Full Text  Link to Item
    • Khan, Muhammad Shahzeb, Gregg C. Fonarow, Ali Ahmed, Stephen J. Greene, Muthiah Vaduganathan, Hassan Khan, Catherine Marti, Mihai Gheorghiade, and Javed Butler. “Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.” Circ Heart Fail 10, no. 8 (August 2017). https://doi.org/10.1161/CIRCHEARTFAILURE.117.003956.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Ankeet S. Bhatt, Dianne Gallup, Kevin J. Anstrom, Javed Butler, Adam D. DeVore, G Michael Felker, et al. “Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).” Am J Cardiol 120, no. 1 (July 1, 2017): 98–105. https://doi.org/10.1016/j.amjcard.2017.03.249.
       Full Text  Link to Item
    • Greene, Stephen J., Muthiah Vaduganathan, and Mihai Gheorghiade. “Finding the road to recovery: therapeutic and clinical trial implications of dysfunctional viable myocardium in heart failure with reduced ejection fraction.” Eur J Heart Fail 19, no. 7 (July 2017): 870–72. https://doi.org/10.1002/ejhf.842.
       Full Text  Link to Item
    • Greene, Stephen J., Adrian F. Hernandez, Allison Dunning, Andrew P. Ambrosy, Paul W. Armstrong, Javed Butler, Lukasz P. Cerbin, et al. “Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.” J Am Coll Cardiol 69, no. 25 (June 27, 2017): 3029–39. https://doi.org/10.1016/j.jacc.2017.04.043.
       Full Text  Link to Item
    • Senni, Michele, Stephen J. Greene, Javed Butler, Gregg C. Fonarow, and Mihai Gheorghiade. “Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle?” Can J Cardiol 33, no. 6 (June 2017): 768–76. https://doi.org/10.1016/j.cjca.2017.03.013.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Lukasz P. Cerbin, Adam D. DeVore, Stephen J. Greene, William E. Kraus, Christopher M. O’Connor, Ileana L. Piña, et al. “Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.” Am Heart J 186 (April 2017): 130–38. https://doi.org/10.1016/j.ahj.2016.12.017.
       Full Text  Link to Item
    • Brown, David A., Justin B. Perry, Mitchell E. Allen, Hani N. Sabbah, Brian L. Stauffer, Saame Raza Shaikh, John G. F. Cleland, et al. “Expert consensus document: Mitochondrial function as a therapeutic target in heart failure.” Nat Rev Cardiol 14, no. 4 (April 2017): 238–50. https://doi.org/10.1038/nrcardio.2016.203.
       Full Text  Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, Scott D. Solomon, Haris P. Subacius, Andrew P. Ambrosy, Muthiah Vaduganathan, Aldo P. Maggioni, et al. “Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.” Eur J Heart Fail 19, no. 4 (April 2017): 552–62. https://doi.org/10.1002/ejhf.674.
       Full Text  Link to Item
    • Greene, Stephen J., Stephen E. Epstein, Raymond J. Kim, Arshed A. Quyyumi, Robert T. Cole, Allen S. Anderson, Jane E. Wilcox, et al. “Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.” J Cardiovasc Med (Hagerstown) 18, no. 4 (April 2017): 283–90. https://doi.org/10.2459/JCM.0000000000000303.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Ayman Samman-Tahhan, Ravi B. Patel, Anita Kelkar, Lampros Papadimitriou, Vasiliki V. Georgiopoulou, Stephen J. Greene, et al. “Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review.” Int J Cardiol 230 (March 1, 2017): 301–3. https://doi.org/10.1016/j.ijcard.2016.12.119.
       Full Text  Link to Item
    • Butler, Javed, Stephen E. Epstein, Stephen J. Greene, Arshed A. Quyyumi, Sergey Sikora, Raymond J. Kim, Allen S. Anderson, et al. “Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.” Circ Res 120, no. 2 (January 20, 2017): 332–40. https://doi.org/10.1161/CIRCRESAHA.116.309717.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Lukasz P. Cerbin, Paul W. Armstrong, Javed Butler, Adrian Coles, Adam D. DeVore, Mark E. Dunlap, et al. “Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.” Jacc Heart Fail 5, no. 1 (January 2017): 1–13. https://doi.org/10.1016/j.jchf.2016.09.012.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Lukasz P. Cerbin, Paul W. Armstrong, Laved Butler, Adrian Coles, Adam D. DeVore, Mark E. Dunlap, et al. “Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial.” Jacc Heart Failure 5, no. 1 (January 1, 2017): 3–13.
       Link to Item
    • Barroso, Michael Coll, Frank Kramer, Stephen J. Greene, Daniel Scheyer, Till Köhler, Martin Karoff, Melchior Seyfarth, Mihai Gheorghiade, and Wilfried Dinh. “Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction.” Bmc Cardiovasc Disord 16, no. 1 (October 21, 2016): 199. https://doi.org/10.1186/s12872-016-0376-2.
       Full Text  Link to Item
    • Greene, Stephen J., Adrian F. Hernandez, Jie-Lena Sun, Marco Metra, Javed Butler, Andrew P. Ambrosy, Justin A. Ezekowitz, et al. “Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).” Circ Heart Fail 9, no. 9 (September 2016). https://doi.org/10.1161/CIRCHEARTFAILURE.116.002986.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Ravi B. Patel, Stephen J. Greene, and Mihai Gheorghiade. “Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization.” Eur J Heart Fail 18, no. 9 (September 2016): 1190–92. https://doi.org/10.1002/ejhf.598.
       Full Text  Link to Item
    • Chioncel, Ovidiu, Sean P. Collins, Stephen J. Greene, Andrew P. Ambrosy, Muthiah Vaduganathan, Cezar Macarie, Javed Butler, and Mihai Gheorghiade. “Natriuretic peptide-guided management in heart failure.” J Cardiovasc Med (Hagerstown) 17, no. 8 (August 2016): 556–68. https://doi.org/10.2459/JCM.0000000000000329.
       Full Text  Link to Item
    • Temporelli, P. L., S. Buda, and S. J. Greene. “Role of omega-3 polyunsaturated fatty acids after acute coronary syndrome.” Giornale Italiano Di Cardiologia 17, no. 7 (July 1, 2016): 3S-10S.
    • Temporelli, Pier Luigi, Stefano Buda, and Stephen J. Greene. “[Role of omega-3 polyunsaturated fatty acids after acute coronary syndrome].” G Ital Cardiol (Rome) 17, no. 7 Suppl 1 (July 2016): 3–10. https://doi.org/10.1714/2336.25080.
       Full Text  Link to Item
    • Mentz, Robert J., Lothar Roessig, Barry H. Greenberg, Naoki Sato, Kaori Shinagawa, Daniel Yeo, Bernard W. K. Kwok, et al. “Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps.” Jacc Heart Fail 4, no. 6 (June 2016): 419–27. https://doi.org/10.1016/j.jchf.2016.01.013.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Hassan Khan, James E. Udelson, Robert J. Mentz, Ovidiu Chioncel, Stephen J. Greene, Muthiah Vaduganathan, et al. “Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial.” Circ Heart Fail 9, no. 5 (May 2016). https://doi.org/10.1161/CIRCHEARTFAILURE.115.002458.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Christopher J. Larson, Sanjiv J. Shah, Stephen J. Greene, John G. F. Cleland, Wilson S. Colucci, Preston Dunnmon, et al. “Developing New Treatments for Heart Failure: Focus on the Heart.” Circ Heart Fail 9, no. 5 (May 2016). https://doi.org/10.1161/CIRCHEARTFAILURE.115.002727.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Catherine N. Marti, Robert J. Mentz, Stephen J. Greene, Andrew P. Ambrosy, Haris P. Subacius, Gregg C. Fonarow, et al. “Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure.” Am J Cardiol 117, no. 7 (April 1, 2016): 1144–50. https://doi.org/10.1016/j.amjcard.2015.12.059.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Adrian F. Hernandez, Paul W. Armstrong, Javed Butler, Allison Dunning, Justin A. Ezekowitz, G Michael Felker, et al. “The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.” Eur J Heart Fail 18, no. 3 (March 2016): 306–13. https://doi.org/10.1002/ejhf.420.
       Full Text  Link to Item
    • Samman Tahhan, Ayman, Muthiah Vaduganathan, Anita Kelkar, Vasiliki V. Georgiopoulou, Andreas P. Kalogeropoulos, Stephen J. Greene, Gregg C. Fonarow, Mihai Gheorghiade, and Javed Butler. “Trends in Heart Failure Clinical Trials From 2001-2012.” J Card Fail 22, no. 3 (March 2016): 171–79. https://doi.org/10.1016/j.cardfail.2015.06.014.
       Full Text  Link to Item
    • Cook, Thomas D., Stephen J. Greene, Andreas P. Kalogeropoulos, Gregg C. Fonarow, Ryan Zea, Karl Swedberg, Faiez Zannad, et al. “Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial).” Am J Cardiol 117, no. 4 (February 15, 2016): 611–16. https://doi.org/10.1016/j.amjcard.2015.11.050.
       Full Text  Link to Item
    • Greene, Stephen J., Pier Luigi Temporelli, Umberto Campia, Muthiah Vaduganathan, Luca Degli Esposti, Stefano Buda, Chiara Veronesi, Javed Butler, and Savina Nodari. “Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction.” Am J Cardiol 117, no. 3 (February 1, 2016): 340–46. https://doi.org/10.1016/j.amjcard.2015.10.050.
       Full Text  Link to Item
    • Greene, Stephen J., Hani N. Sabbah, Javed Butler, Adriaan A. Voors, Barbara E. Albrecht-Küpper, Hans-Dirk Düngen, Wilfried Dinh, and Mihai Gheorghiade. “Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure.” Heart Fail Rev 21, no. 1 (January 2016): 95–102. https://doi.org/10.1007/s10741-015-9522-7.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Stephen J. Greene, Javed Butler, Gerasimos Filippatos, Carolyn S. P. Lam, Aldo P. Maggioni, Piotr Ponikowski, et al. “Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.” Jama 314, no. 21 (December 1, 2015): 2251–62. https://doi.org/10.1001/jama.2015.15734.
       Full Text  Link to Item
    • Chioncel, Ovidiu, Sean P. Collins, Stephen J. Greene, Andrew P. Ambrosy, Muthiah Vaduganathan, Cezar Macarie, Javed Butler, and Mihai Gheorghiade. “Natriuretic peptide-guided management in heart failure.” J Cardiovasc Med (Hagerstown), November 7, 2015. https://doi.org/10.2459/JCM.0000000000000392.
       Full Text  Link to Item
    • Kelkar, Anita A., Javed Butler, Erik B. Schelbert, Stephen J. Greene, Arshed A. Quyyumi, Robert O. Bonow, Ira Cohen, et al. “Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells.” J Am Coll Cardiol 66, no. 18 (November 3, 2015): 2038–47. https://doi.org/10.1016/j.jacc.2015.09.010.
       Full Text  Link to Item
    • Butler, Javed, Mihai Gheorghiade, Anita Kelkar, Gregg C. Fonarow, Stefan Anker, Stephen J. Greene, Lampros Papadimitriou, et al. “In-hospital worsening heart failure.” Eur J Heart Fail 17, no. 11 (November 2015): 1104–13. https://doi.org/10.1002/ejhf.333.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Robert J. Mentz, Arun Krishnamoorthy, Stephen J. Greene, and Harry W. Severance. “Identifying Barriers and Practical Solutions to Conducting Site-Based Research in North America: Exploring Acute Heart Failure Trials As a Case Study.” Heart Fail Clin 11, no. 4 (October 2015): 581–89. https://doi.org/10.1016/j.hfc.2015.07.002.
       Full Text  Open Access Copy  Link to Item
    • Greene, Stephen J., Lora AlKhawam, Andrew P. Ambrosy, Muthiah Vaduganathan, and Robert J. Mentz. “Hospitalized Heart Failure in the United States: Lessons Learned from Clinical Trial Populations.” Heart Fail Clin 11, no. 4 (October 2015): 591–601. https://doi.org/10.1016/j.hfc.2015.07.003.
       Full Text  Link to Item
    • Greene, Stephen J., and Gregg C. Fonarow. “Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction?” Eur J Heart Fail 17, no. 10 (October 2015): 991–93. https://doi.org/10.1002/ejhf.337.
       Full Text  Link to Item
    • Khan, Hassan, Stephen J. Greene, Gregg C. Fonarow, Andreas P. Kalogeropoulos, Andrew P. Ambrosy, Aldo P. Maggioni, Faiez Zannad, et al. “Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.” Eur J Heart Fail 17, no. 10 (October 2015): 1022–31. https://doi.org/10.1002/ejhf.282.
       Full Text  Link to Item
    • Greene, Stephen J., and Mihai Gheorghiade. “Same protocol, different continents, different patients: should we continue to conduct global heart failure trials?” Eur J Heart Fail 17, no. 9 (September 2015): 875–78. https://doi.org/10.1002/ejhf.335.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Ayman S. Tahhan, Stephen J. Greene, Anita A. Kelkar, Vasiliki V. Georgiopoulou, Andreas P. Kalogeropoulos, Gregg C. Fonarow, Mihai Gheorghiade, and Javed Butler. “Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).” Am J Cardiol 116, no. 2 (July 15, 2015): 307–12. https://doi.org/10.1016/j.amjcard.2015.03.062.
       Full Text  Link to Item
    • Harinstein, Matthew E., Javed Butler, Stephen J. Greene, Gregg C. Fonarow, Norman L. Stockbridge, Christopher M. O’Connor, Marc A. Pfeffer, et al. “Site selection for heart failure clinical trials in the USA.” Heart Fail Rev 20, no. 4 (July 2015): 375–83. https://doi.org/10.1007/s10741-015-9473-z.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Javed Butler, Lothar Roessig, Gregg C. Fonarow, Stephen J. Greene, Marco Metra, Gadi Cotter, et al. “Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations.” Heart Fail Rev 20, no. 4 (July 2015): 393–400. https://doi.org/10.1007/s10741-015-9485-8.
       Full Text  Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, Scott D. Solomon, Haris Subacius, Aldo P. Maggioni, Michael Böhm, Eldrin F. Lewis, Faiez Zannad, Mihai Gheorghiade, and Mihai ASTRONAUT Investigators and Coordinators. “Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial.” Eur J Heart Fail 17, no. 6 (June 2015): 591–600. https://doi.org/10.1002/ejhf.280.
       Full Text  Link to Item
    • Echouffo-Tcheugui, Justin B., Stephen J. Greene, Lampros Papadimitriou, Faiez Zannad, Clyde W. Yancy, Mihai Gheorghiade, and Javed Butler. “Population risk prediction models for incident heart failure: a systematic review.” Circ Heart Fail 8, no. 3 (May 2015): 438–47. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001896.
       Full Text  Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, and Javed Butler. “REPORT-HF: the unique blend of global heart failure registry and longitudinal cohort study.” Eur J Heart Fail 17, no. 5 (May 2015): 472–74. https://doi.org/10.1002/ejhf.264.
       Full Text  Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, Muthiah Vaduganathan, Sadiya S. Khan, Javed Butler, and Mihai Gheorghiade. “The vulnerable phase after hospitalization for heart failure.” Nat Rev Cardiol 12, no. 4 (April 2015): 220–29. https://doi.org/10.1038/nrcardio.2015.14.
       Full Text  Link to Item
    • Greene, Stephen J., and Mihai Gheorghiade. “Reply: considerations for drug development for heart failure.” J Am Coll Cardiol 65, no. 10 (March 17, 2015): 1061–62. https://doi.org/10.1016/j.jacc.2014.11.064.
       Full Text  Link to Item
    • Maisel, Alan, Yang Xue, Stephen J. Greene, Peter S. Pang, James L. Januzzi, Ileana L. Piña, Christopher DeFilippi, and Javed Butler. “The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.” J Card Fail 21, no. 3 (March 2015): 233–39. https://doi.org/10.1016/j.cardfail.2014.11.009.
       Full Text  Link to Item
    • Dei Cas, Alessandra, Sadiya S. Khan, Javed Butler, Robert J. Mentz, Robert O. Bonow, Angelo Avogaro, Diethelm Tschoepe, et al. “Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure.” Jacc Heart Fail 3, no. 2 (February 2015): 136–45. https://doi.org/10.1016/j.jchf.2014.08.004.
       Full Text  Link to Item
    • Greene, Stephen J., Aldo P. Maggioni, Gregg C. Fonarow, Scott D. Solomon, Michael Böhm, Albert Kandra, Margaret F. Prescott, et al. “Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.” Eur J Heart Fail 17, no. 1 (January 2015): 98–108. https://doi.org/10.1002/ejhf.201.
       Full Text  Link to Item
    • Parrinello, Gaspare, Stephen J. Greene, Daniele Torres, Michael Alderman, Joseph Vincent Bonventre, Pietro Di Pasquale, Luna Gargani, et al. “Water and sodium in heart failure: a spotlight on congestion.” Heart Fail Rev 20, no. 1 (January 2015): 13–24. https://doi.org/10.1007/s10741-014-9438-7.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Robert J. Mentz, Stephen J. Greene, Michele Senni, Naoki Sato, Savina Nodari, Javed Butler, and Mihai Gheorghiade. “Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists.” Expert Rev Cardiovasc Ther 13, no. 7 (2015): 799–809. https://doi.org/10.1586/14779072.2015.1053872.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Andrew P. Ambrosy, Robert J. Mentz, Haris P. Subacius, Ovidiu Chioncel, Aldo P. Maggioni, et al. “Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).” Am J Cardiol 114, no. 11 (December 1, 2014): 1713–21. https://doi.org/10.1016/j.amjcard.2014.09.008.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Gregg C. Fonarow, Adriaan A. Voors, Javed Butler, and Mihai Gheorghiade. “Hemoconcentration-guided diuresis in heart failure.” Am J Med 127, no. 12 (December 2014): 1154–59. https://doi.org/10.1016/j.amjmed.2014.06.009.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Andrew P. Ambrosy, and Mihai Gheorghiade. “Lipids, statins, and clinical outcomes in heart failure: rethinking the data.” Heart Fail Rev 19, no. 6 (November 2014): 695–98. https://doi.org/10.1007/s10741-014-9423-1.
       Full Text  Link to Item
    • Greene, Stephen J., and Mihai Gheorghiade. “Matching mechanism of death with mechanism of action: considerations for drug development for hospitalized heart failure.” J Am Coll Cardiol 64, no. 15 (October 14, 2014): 1599–1601. https://doi.org/10.1016/j.jacc.2014.06.1199.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Alessandra Dei Cas, Robert J. Mentz, Stephen J. Greene, Sadiya Khan, Haris P. Subacius, Ovidiu Chioncel, et al. “Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial).” Am J Cardiol 114, no. 5 (September 1, 2014): 743–50. https://doi.org/10.1016/j.amjcard.2014.05.064.
       Full Text  Link to Item
    • Greene, Stephen J., Ami N. Shah, Javed Butler, Andrew P. Ambrosy, Stefan D. Anker, Ovidiu Chioncel, Sean P. Collins, et al. “Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.” Am Heart J 168, no. 2 (August 2014): 142–49. https://doi.org/10.1016/j.ahj.2014.05.009.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Gregg C. Fonarow, Robert O. Bonow, Javed Butler, and Mihai Gheorghiade. “Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy?” Am J Med 127, no. 7 (July 2014): 574–78. https://doi.org/10.1016/j.amjmed.2014.01.041.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, and Stephen J. Greene. “Influence of chronic kidney disease on warfarin therapy for atrial fibrillation.” Jama 311, no. 24 (June 25, 2014): 2541–42. https://doi.org/10.1001/jama.2014.5576.
       Full Text  Link to Item
    • Mentz, Robert J., Stephen J. Greene, Andrew P. Ambrosy, Muthiah Vaduganathan, Haris P. Subacius, Karl Swedberg, Aldo P. Maggioni, et al. “Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial.” Circ Heart Fail 7, no. 3 (May 2014): 401–8. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000840.
       Full Text  Link to Item
    • Greene, Stephen J., Lora Alkhawam, and Muthiah Vaduganathan. “Dual antiplatelet therapy after stent implantation.” Jama 311, no. 14 (April 9, 2014): 1446. https://doi.org/10.1001/jama.2014.2092.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Gregg C. Fonarow, Javed Butler, Ovidiu Chioncel, Stephen J. Greene, Muthiah Vaduganathan, Savina Nodari, et al. “The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.” J Am Coll Cardiol 63, no. 12 (April 1, 2014): 1123–33. https://doi.org/10.1016/j.jacc.2013.11.053.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Javed Butler, and Mihai Gheorghiade. “Endpoints for diuresis: are we there yet?” J Am Coll Cardiol 63, no. 8 (March 4, 2014): 838–39. https://doi.org/10.1016/j.jacc.2013.04.108.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Muthiah Vaduganathan, Stephen J. Greene, Robert J. Mentz, Kirkwood F. Adams, Stefan D. Anker, Malcolm Arnold, et al. “Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.” Heart Fail Rev 19, no. 2 (March 2014): 135–52. https://doi.org/10.1007/s10741-012-9361-8.
       Full Text  Link to Item
    • Greene, Stephen J., Mihai Gheorghiade, Barry A. Borlaug, Burkert Pieske, Muthiah Vaduganathan, John C. Burnett, Lothar Roessig, et al. “The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.” J Am Heart Assoc 2, no. 6 (December 11, 2013): e000536. https://doi.org/10.1161/JAHA.113.000536.
       Full Text  Link to Item
    • Greene, Stephen J., Mihai Gheorghiade, Muthiah Vaduganathan, Andrew P. Ambrosy, Robert J. Mentz, Haris Subacius, Aldo P. Maggioni, et al. “Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.” Eur J Heart Fail 15, no. 12 (December 2013): 1401–11. https://doi.org/10.1093/eurjhf/hft110.
       Full Text  Link to Item
    • Greene, Stephen J., Muthiah Vaduganathan, Jane E. Wilcox, Matthew E. Harinstein, Aldo P. Maggioni, Haris Subacius, Faiez Zannad, et al. “The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.” Jacc Heart Fail 1, no. 6 (December 2013): 488–96. https://doi.org/10.1016/j.jchf.2013.08.005.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Andrew P. Ambrosy, Robert J. Mentz, Gregg C. Fonarow, Faiez Zannad, Aldo P. Maggioni, et al. “Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).” Am J Cardiol 112, no. 11 (December 1, 2013): 1763–69. https://doi.org/10.1016/j.amjcard.2013.07.020.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Muthiah Vaduganathan, Gregg C. Fonarow, Stephen J. Greene, Barry H. Greenberg, Peter P. Liu, Barry M. Massie, et al. “Anticoagulation in heart failure: current status and future direction.” Heart Fail Rev 18, no. 6 (November 2013): 797–813. https://doi.org/10.1007/s10741-012-9343-x.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Javed Butler, Hani N. Sabbah, Eduard Shantsila, Gregory Y. H. Lip, and Mihai Gheorghiade. “The immunological axis in heart failure: importance of the leukocyte differential.” Heart Fail Rev 18, no. 6 (November 2013): 835–45. https://doi.org/10.1007/s10741-012-9352-9.
       Full Text  Link to Item
    • Maggioni, Aldo P., Stephen J. Greene, Gregg C. Fonarow, Michael Böhm, Faiez Zannad, Scott D. Solomon, Eldrin F. Lewis, et al. “Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.” Eur Heart J 34, no. 40 (October 2013): 3117–27. https://doi.org/10.1093/eurheartj/eht342.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Stephen J. Greene, Piotr Ponikowski, Aldo P. Maggioni, Jerzy Korewicki, Cezar Macarie, Marco Metra, et al. “Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction.” Eur J Heart Fail 15, no. 6 (June 2013): 679–89. https://doi.org/10.1093/eurjhf/hft023.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Kanan Patel, Gerasimos Filippatos, Stefan D. Anker, Dirk J. van Veldhuisen, John G. F. Cleland, Marco Metra, et al. “Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.” Eur J Heart Fail 15, no. 5 (May 2013): 551–59. https://doi.org/10.1093/eurjhf/hft010.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Michael Böhm, Stephen J. Greene, Gregg C. Fonarow, Eldrin F. Lewis, Faiez Zannad, Scott D. Solomon, et al. “Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.” Jama 309, no. 11 (March 20, 2013): 1125–35. https://doi.org/10.1001/jama.2013.1954.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Catherine N. Marti, Hani N. Sabbah, Lothar Roessig, Stephen J. Greene, Michael Böhm, John C. Burnett, et al. “Soluble guanylate cyclase: a potential therapeutic target for heart failure.” Heart Fail Rev 18, no. 2 (March 2013): 123–34. https://doi.org/10.1007/s10741-012-9323-1.
       Full Text  Link to Item
    • Greene, Stephen J., Muthiah Vaduganathan, Laura Lupi, Andrew P. Ambrosy, Robert J. Mentz, Marvin A. Konstam, Savina Nodari, et al. “Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).” Am J Cardiol 111, no. 4 (February 15, 2013): 574–81. https://doi.org/10.1016/j.amjcard.2012.10.042.
       Full Text  Link to Item
    • Ambrosy, Andrew P., Muthiah Vaduganathan, Robert J. Mentz, Stephen J. Greene, Haris Subačius, Marvin A. Konstam, Aldo P. Maggioni, Karl Swedberg, and Mihai Gheorghiade. “Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.” Am Heart J 165, no. 2 (February 2013): 216–25. https://doi.org/10.1016/j.ahj.2012.11.004.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Stephen J. Greene, Andrew P. Ambrosy, Mihai Gheorghiade, and Javed Butler. “The disconnect between phase II and phase III trials of drugs for heart failure.” Nat Rev Cardiol 10, no. 2 (February 2013): 85–97. https://doi.org/10.1038/nrcardio.2012.181.
       Full Text  Link to Item
    • Lanfear, David E., Hani N. Sabbah, Steven R. Goldsmith, Stephen J. Greene, Andrew P. Ambrosy, Angela J. Fought, Mary J. Kwasny, et al. “Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.” Circ Heart Fail 6, no. 1 (January 2013): 47–52. https://doi.org/10.1161/CIRCHEARTFAILURE.112.970012.
       Full Text  Link to Item
    • Greene, Stephen J., Matthew E. Harinstein, Muthiah Vaduganathan, Haris Subačius, Marvin A. Konstam, Faiez Zannad, Aldo P. Maggioni, et al. “Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).” Am J Cardiol 110, no. 11 (December 1, 2012): 1657–62. https://doi.org/10.1016/j.amjcard.2012.07.035.
       Full Text  Link to Item
    • Vaduganathan, Muthiah, Andrew P. Ambrosy, Stephen J. Greene, Robert J. Mentz, Haris P. Subacius, Aldo P. Maggioni, Karl Swedberg, et al. “Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.” Circ Heart Fail 5, no. 6 (November 2012): 750–58. https://doi.org/10.1161/CIRCHEARTFAILURE.112.970525.
       Full Text  Link to Item
    • Gheorghiade, Mihai, Stephen J. Greene, Gerasimos Filippatos, Erland Erdmann, Roberto Ferrari, Phillip D. Levy, Aldo Maggioni, Christina Nowack, Alexandre Mebazaa, and Alexandre COMPOSE Investigators and Coordinators. “Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes.” Eur J Heart Fail 14, no. 9 (September 2012): 1056–66. https://doi.org/10.1093/eurjhf/hfs093.
       Full Text  Link to Item
    • Adare, A., C. Aidala, N. N. Ajitanand, Y. Akiba, H. Al-Bataineh, J. Alexander, A. Angerami, et al. “Quadrupole Anisotropy in Dihadron Azimuthal Correlations in Centrald+AuCollisions atsNN=200  GeV.” Physical Review Letters 111, no. 21 (n.d.). https://doi.org/10.1103/physrevlett.111.212301.
       Full Text

  • Conference Papers

    • Carnicelli, Anthony P., Stephen Greene, Steven Lippmann, Robert J. Mentz, Melissa Greiner, Chantelle Hardy, Bradley G. Hammill, et al. “Sacubitril/valsartan Initiation and Adherence Patterns Following Hospitalization for Heart Failure.” In Journal of Cardiac Failure, 26:S91–S91, 2020.
       Link to Item
    • Chukwurah, Marius I., Marat Fudim, Stephen J. Greene, Jie-Lena Sun, Brooke Alhanti, Randall C. Starling, and Robert J. Mentz. “Assessing for a Differential Treatment Effect with Nesiritide by Body Mass Index.” In Journal of Cardiac Failure, 26:S66–67, 2020.
       Link to Item
    • Ezekowitz, Justin, Robert J. Mentz, Cynthia M. Westerhout, Nancy K. Sweitzer, Michael M. Givertz, Ileana L. Pina, Christopher M. O’Connor, et al. “Non-participation in a Heart Failure Clinical Trial: Perspectives and Opportunities from the VICTORIA Trial and Simultaneous Registry.” In Journal of Cardiac Failure, 26:S65–S65, 2020.
       Link to Item
    • II, Sullivan Lonnie T., Stephen Greene, Jie-Lena Sun, Christopher M. O’Connor, Brooke Alhanti, David Whellan, Ileana L. Pina, William E. Kraus, and Robert J. Mentz. “Nitrate Use And Changes In Functional Status In Black Patients With Chronic Heart Failure With Reduced Ejection Fraction: Insights From The HFACTION Trial.” In Journal of Cardiac Failure, 26:S57–58, 2020.
       Link to Item
    • Blumer, Vanessa, Stephen Greene, Angie Wu, Joann Lindenfeld, Brooke Alhanti, Javed Butler, Justin Ezekowitz, Adrian Hernandez, Mariell Jessup, and Robert John Mentz. “DIFFERENCES IN THERAPY AND DECONGESTION BETWEEN MEN AND WOMEN HOSPITALIZED FOR ACUTE HEART FAILURE: FINDINGS FROM ASCEND-HF.” In Journal of the American College of Cardiology, 75:790–790. ELSEVIER SCIENCE INC, 2020.
       Link to Item
    • Hamo, Carine, Adam DeVore, Gregg C. Fonarow, Stephen Greene, Muthiah Vaduganathan, Clyde W. Yancy, Paul A. Heidenreich, Di Lu, Roland Matsouaka, and Javed Butler. “TEMPORAL TRENDS IN SEVERITY IN CLINICAL RISK PROFILES AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE.” In Journal of the American College of Cardiology, 75:924–924. ELSEVIER SCIENCE INC, 2020.
       Link to Item
    • Greene, Stephen J., Christopher M. O’Connor, Jie-Lena Sun, Mona Fiuzat, William E. Kraus, Brooke Alhanti, Ileana L. Pina, David Whellan, and Robert J. Mentz. “Clinical Outcomes Associated With Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction: From the HF-ACTION Trial.” In Circulation, Vol. 140, 2019.
       Link to Item
    • Ho, Annie H., Ayman Samman Tahhan, Muthiah Vaduganathan, Stephen J. Greene, Alaaeddin Alrohaibani, Gregg C. Fonarow, Javed Butler, et al. “Representation of Women Authors in Contemporary Heart Failure Clinical Trials.” In Circulation, Vol. 140, 2019.
       Link to Item
    • Greene, Stephen J., Steven J. Lippmann, Robert J. Mentz, Melissa A. Greiner, N Chantelle Hardy, Chun-Lan Chang, Bradley G. Hammill, et al. “Clinical Effectiveness of Sacubitril/valsartan among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction.” In Journal of Cardiac Failure, 25:937–937. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.11.003.
       Full Text
    • Greene, Stephen, Gregg Fonarow, Adam DeVore, Puza Sharma, Muthiah Vaduganathan, Nancy Albert, Carol Duffy, et al. “LONGITUDINAL CHANGES IN MEDICATION DOSING AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: FROM THE CHAMP-HF REGISTRY.” In Journal of the American College of Cardiology, 73:707–707. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)31315-4.
       Full Text
    • Fudim, Marat, Andrew P. Ambrosy, Jie-Lena Sun, Kevin J. Anstrom, Bradley A. Bart, Javed Butler, Omar AbouEzzeddine, et al. “High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.” In J Am Heart Assoc, 7:e010364, 2018. https://doi.org/10.1161/JAHA.118.010364.
       Full Text  Link to Item
    • Greene, Stephen J., Adam D. DeVore, Sheng Shubin, Javed Butler, Robert M. Califf, Gregg C. Fonarow, Adrian F. Hernandez, et al. “Representativeness of an Acute Heart Failure Trial by Race and Sex: Results From a Joint Analysis of the ASCEND-HF Trial and the GWTG-HF Registry.” In Circulation, Vol. 138, 2018.
       Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, Scott D. Solomon, Haris P. Subacius, Muthiah Vaduganathan, Andrew P. Ambrosy, Marat Fudim, et al. “Timing of Randomization During Hospitalization for Heart Failure, Patient Profile, and Clinical Trial Performance: Insights From the ASTRONAUT Trial.” In Circulation, Vol. 138, 2018.
       Link to Item
    • Greene, Stephen J., Lauren Wilson, Siddique Abbasi, Akeem Yusuf, and Bradley G. Hammill. “Outpatient Use of Intravenous Diuretics for Treatment of Heart Failure: Temporal Trends and Associations With 30-Day Mortality and Readmission Following Hospitalization for Heart Failure.” In Circulation, Vol. 138, 2018.
       Link to Item
    • Khan, Muhammad S., Muhammad M. Memon, Muthiah Vaduganathan, Stephen J. Greene, Mohammad H. Murad, Michael E. Hall, Filippos Triposkiadis, and Javed Butler. “Meta-Analysis Assessing the Association Between Left Atrial Function and Heart Failure With Preserved Ejection Fraction.” In Circulation, Vol. 138, 2018.
       Link to Item
    • Patel, Ravi B., Muthiah Vaduganathan, Aruna Rikhi, Hrishikesh Chakraborty, Stephen J. Greene, Adrian F. Hernandez, G Michael Felker, Margaret Redfield, Javed Butler, and Sanjiv J. Shah. “History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure: A Pooled, Patient-Level Analysis of the Heart Failure Network.” In Circulation, Vol. 138, 2018.
       Link to Item
    • Greene, S. J., R. J. Mentz, A. T. Limkakeng, T. Irons, T. Truong, C. L. Green, C. Nowak, S. Griffin, J. Leahy, and P. S. Pang. “67EMF Comparison of Dyspnea Measurement Instruments in Acute Heart Failure: Results From the DYSPNEA-AHF Study.” In Annals of Emergency Medicine, 72:S29–S29. Elsevier BV, 2018. https://doi.org/10.1016/j.annemergmed.2018.08.072.
       Full Text
    • Ammon, Susan, Biykem Bozkurt, Eugene Chung, Robert Cole, Patrice Desvigne-Nickens, Mona Fiuzat, Stephen Greene, et al. “Heart Failure Society of America Research Network Survey.” In Journal of Cardiac Failure, 24:S9–S9. Elsevier BV, 2018. https://doi.org/10.1016/j.cardfail.2018.07.031.
       Full Text
    • Tahhan, Ayman Samman, Muthiah Vaduganathan, Stephen Greene, Gregg Fonarow, Mona Fiuzat, Mariell Jessup, JoAnn Lindenfeld, Christopher O’Connor, and Javed Butler. “Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials.” In Journal of Cardiac Failure, 24:S58–59. Elsevier BV, 2018. https://doi.org/10.1016/j.cardfail.2018.07.262.
       Full Text
    • Fudim, M Marat, S. J. Doerfler, A. Coles, S. J. Greene, L. B. Cooper, M. Fiuzat, C. M. O’connor, J. G. Rogers, and R. J. Mentz. “Worsening renal function during decongestion among patients hospitalized for heart failure: findings from the escape trial.” In European Journal of Heart Failure, 20:548–548. WILEY, 2018.
       Link to Item
    • Greene, Stephen, Adrian Hernandez, Jie Sun, Javed Butler, Paul Armstrong, Justin Ezekowitz, Marco Metra, et al. “PRIOR HEART FAILURE HOSPITALIZATION AMONG PATIENTS HOSPITALIZED FOR WORSENING CHRONIC HEART FAILURE: FROM THE ASCEND-HF TRIAL.” In Journal of the American College of Cardiology, 71:A796–A796. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)31337-8.
       Full Text
    • Greene, Stephen, Muthiah Vaduganathan, Muhammad Khan, George Bakris, Matthew Weir, Jonathan Seltzer, Naveed Sattar, et al. “SYSTEMATIC REVIEW OF PREVALENT AND INCIDENT HEART FAILURE IN CARDIOVASCULAR OUTCOME TRIALS OF PATIENTS WITH TYPE 2 DIABETES.” In Journal of the American College of Cardiology, 71:A797–A797. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)31338-x.
       Full Text
    • Greene, Stephen J., Adrian F. Hernandez, Jie-Lena Sun, Javed Butler, Paul W. Armstrong, Justin A. Ezekowitz, Faiez Zannad, et al. “Country Income Level, Protocol Completion, and Trial Endpoints Among Patients With Acute Heart Failure: Insights From the ASCEND-HF Trial.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.
       Link to Item
    • Greene, Stephen J., Gregg C. Fonarow, Baljash S. Cheema, Andrew P. Ambrosy, Muthiah Vaduganathan, Haris P. Subacius, Javed Butler, and Mihai Gheorghiade. “Clinical Profile and Prognostic Significance of Post-Discharge Hemodilution Among Patients Hospitalized for Heart Failure: Insights From the EVEREST Trial.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.
       Link to Item
    • Greene, Stephen, Nancy Luo, Robert J. Mentz, Chantelle Hardy, Warren K. Laskey, Paul A. Heidenreich, Clyde W. Yancy, et al. “Home-Time as a Novel Post-Discharge Outcome for Patients Hospitalized With Heart Failure.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.
       Link to Item
    • Vaduganathan, Muthiah, Robert J. Mentz, Haris Subacius, Ravi B. Patel, Neal A. Chatterjee, Stephen J. Greene, Andrew P. Ambrosy, et al. “Sudden Cardiac Death Risk After Hospitalization for Heart Failure: Insights From EVEREST.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.
       Link to Item
    • Ambrosy, Andrew P., Ankeet Bhatt, Amanda Stebbins, Lisa Wruck, Stephen Greene, Marat Fudim, William Kraus, et al. “PREVALENT DIGOXIN USE IS NOT ASSOCIATED WITH INCREASED RISK OF DEATH OR HOSPITALIZATION IN AMBULATORY HEART FAILURE PATIENTS WITH A REDUCED EJECTION FRACTION.” In Journal of the American College of Cardiology, 69:676–676. ELSEVIER SCIENCE INC, 2017.
       Link to Item
    • Bhatt, Ankeet, Sunil Rao, Margaret Infeld, Stephen Greene, Andrew Ambrosy, and James Daubert. “ALTERNATING BUNDLE BRANCH BLOCK: CLINICAL CONSIDERATIONS.” In Journal of the American College of Cardiology, 69:2330–2330. ELSEVIER SCIENCE INC, 2017.
       Link to Item
    • Greene, Stephen, G Michael Felker, Jie Sun, Andrew Ambrosy, Bradley Bart, Javed Butler, Adam DeVore, et al. “HEMOCONCENTRATION DURING MANAGEMENT OF PATIENTS WITH ACUTE HEART FAILURE AND CARDIORENAL SYNDROME: INSIGHTS FROM CARRESS-HF.” In Journal of the American College of Cardiology, 69:767–767. ELSEVIER SCIENCE INC, 2017.
       Link to Item
    • Cerbin, Lukasz, Andrew Ambrosy, Paul Armstrong, Javed Butler, Adrian Coles, Justin Ezekowitz, Stephen Greene, et al. “TIME OF PRESENTATION AMONG PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE (CLINICAL CHARACTERISTICS, INITIAL THERAPIES AND OUTCOMES): INSIGHTS FROM ASCEND-HF.” In Journal of the American College of Cardiology, 69:769–769. Elsevier BV, 2017. https://doi.org/10.1016/s0735-1097(17)34158-x.
       Full Text
    • Ambrosy, Andrew P., Ankeet Bhatt, Dianne Gallup, Kevin Anstrom, Javed Butler, Adam D. DeVore, G. M. Felker, et al. “Trajectory of Congestion Metrics by Ejection Fraction in Acute Heart Failure - Findings From the Heart Failure Network.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • Ambrosy, Andrew P., Ankeet Bhatt, Dianne Gallup, Kevin Anstrom, Javed Butler, Adam D. DeVore, G. M. Felker, et al. “Trajectory of Congestion Metrics by Ejection Fraction in Acute Heart Failure - Findings From the Heart Failure Network.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • Greene, Stephen J., Adrian F. Hernandez, Allison Dunning, Andrew P. Ambrosy, Paul W. Armstrong, Javed Butler, Lukasz Cerbin, et al. “Hospitalization for De Novo versus Worsening Chronic Heart Failure: Insights From the ASCEND-HF Trial.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • Greene, Stephen J., Adrian F. Hernandez, Allison Dunning, Andrew P. Ambrosy, Paul W. Armstrong, Javed Butler, Lukasz Cerbin, et al. “Hospitalization for De Novo versus Worsening Chronic Heart Failure: Insights From the ASCEND-HF Trial.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • Greene, Stephen J., Faiez Zannad, Gregg C. Fonarow, Haris Subacius, Marco Triggiani, Andrew P. Ambrosy, Michael Bohm, et al. “In-hospital and Early Post-discharge Troponin Elevations Among Patients Hospitalized for Heart Failure: Insights From the ASTRONAUT Trial.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • Greene, Stephen J., Faiez Zannad, Gregg C. Fonarow, Haris Subacius, Marco Triggiani, Andrew P. Ambrosy, Michael Bohm, et al. “In-hospital and Early Post-discharge Troponin Elevations Among Patients Hospitalized for Heart Failure: Insights From the ASTRONAUT Trial.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • Ambrosy, Andrew P., Lukasz Cerbin, Adam DeVore, Stephen Greene, William E. Kraus, Christopher O’Connor, Ileana Pina, et al. “AEROBIC EXERCISE TRAINING AND HEALTH STATUS IN AMBULATORY HEART FAILURE PATIENTS WITH A REDUCED EJECTION FRACTION: AN ANALYSIS FROM THE HF-ACTION TRIAL.” In Journal of the American College of Cardiology, 67:1312–1312. Elsevier BV, 2016. https://doi.org/10.1016/s0735-1097(16)31313-4.
       Full Text
    • Ambrosy, Andrew P., Paul W. Armstrong, Javed Butler, Lukasz Cerbin, Adrian Coles, Adam DeVore, Justin A. Ezekowitz, et al. “THE RELATIONSHIP BETWEEN BODY WEIGHT CHANGE DURING HOSPITALIZATION FOR ACUTE HEART FAILURE AND PATIENT CHARACTERISTICS, MARKERS OF CONGESTION, AND OUTCOMES: FINDINGS FROM ASCEND-HF.” In Journal of the American College of Cardiology, 67:1406–1406. Elsevier BV, 2016. https://doi.org/10.1016/s0735-1097(16)31407-3.
       Full Text
    • Greene, Stephen, Adrian Hernandez, Jie-Lena Sun, Marco Metra, Javed Butler, Andrew Ambrosy, Justin Ezekowitz, et al. “INFLUENCE OF CLINICAL TRIAL SITE ENROLLMENT ON PATIENT CHARACTERISTICS, PROTOCOL COMPLETION, AND ENDPOINTS: INSIGHTS FROM THE ASCEND-HF TRIAL.” In Journal of the American College of Cardiology, 67:1554–1554. Elsevier BV, 2016. https://doi.org/10.1016/s0735-1097(16)31555-8.
       Full Text
    • Gheorghiade, Mihai, Aldo P. Maggioni, Carolyn Lam, Eliana Samano, Elisabeth Kraigher-Krainer, Gerasimos Filippatos, Javed Butler, et al. “Oral sGC Stimulator Vericiguat in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction - The SOluble guanylate Cyclase stimulatoR in heArT failurE patientS With REDUCED EF (SOCRATES-REDUCED) Study.” In Circulation, 132:2268–69. LIPPINCOTT WILLIAMS & WILKINS, 2015.
       Link to Item
    • Greene, Stephen John, Muthiah Vaduganathan, Andrew Ambrosy, Marvin Konstam, Haris Subacius, Aldo Maggioni, Robert Mentz, Savina Nodari, Javed Butler, and Mihai Gheorghiade. “INFLUENCE OF URIC ACID LEVEL IN PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM THE EVEREST TRIAL.” In Journal of the American College of Cardiology, 61:E618–E618. Elsevier BV, 2013. https://doi.org/10.1016/s0735-1097(13)60618-x.
       Full Text
    • Mentz, Robert J., Haris Subacius, Alessandra Dei Cas, Andrew P. Ambrosy, Adam DeVore, Muthiah Vaduganathan, Stephen Greene, et al. “MINERALOCORTICOID RECEPTOR ANTAGONISTS IN DIABETIC PATIENTS HOSPITALIZED WITH HEART FAILURE: INSIGHTS FROM THE EVEREST TRIAL.” In Journal of the American College of Cardiology, 61:E708–E708. Elsevier BV, 2013. https://doi.org/10.1016/s0735-1097(13)60708-1.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.